Our Challenge
Cancer care is evolving rapidly. The ability to develop, trial and deploy new drugs and therapies into the NHS is key to delivering better health outcomes for patients. Partnership working between the NHS and academia, and with industry, is essential to develop and deliver the next generation of cancer treatments.
With its population of 3 million and its integrated healthcare system, Wales is ideally placed to be a test bed for industry, research funders and charities looking to develop and deploy new cancer treatments. The Cardiff Cancer Research Hub is a key part of, and point of entry into, this research infrastructure.
Our Expert Clinicians and Researchers
Our Clinical Teams
Our Support Staff and Enablers
Cardiff & Vale University Health Board
Cardiff & Vale University Health Board
One of the largest NHS organisations in the UK providing primary and community-based services, acute services through the University Hospital of Wales and specialist tertiary services for the wider population of Wales.
Cardiff and Vale University Health Board has an international reputation for pioneering clinical research, including its tertiary centre for Blood Cancer treatment and a large portfolio of commercial and non-commercial trials and level 3 transplantation centre.
Research is embedded across the Health Board and our work with academia, commercial organisations, industry and other research centres is critical for improving healthcare.
Velindre University NHS Trust
Velindre University NHS Trust
A specialist NHS provider delivering non-surgical tertiary oncology services to patients through the Velindre Cancer Service and a dedicated cancer centre.
Velindre is recognised internationally for its ground-breaking, innovative research, complex and highly specialised services, state of the art technology, and highly skilled clinical and non-clinical staff. Velindre currently hosts and sponsors a mix of commercial and non-commercial studies across a diverse range of research area.
Our portfolio includes cancer clinical trials, palliative and health care research studies, along with research into blood transfusion and transplantation medicine at the Welsh Blood Service.
Cardiff University
Cardiff University
Wales’ only Russell Group university with a diverse cancer research and innovation portfolio focused on accelerating the transition from lab to clinic.
At Cardiff University we have strengths in tumours and environment, drug discovery and delivery, personalised cancer genetics and clinical trials. These have allowed us to achieve and sustain recognition as a national leader and global competitor in cutting-edge cancer research.
Our cancer research portfolio is diverse, encompassing cancer biology, drug discovery, prevention and early diagnosis. By applying our expertise and knowledge across scientific disciplines, we aim improve our fundamental understanding of cancer to improve the treatments for patients with cancer.
